Spotlight on Surgery

Credits: 0.75 CME
CMV & AMR in Transplant: A Focus on Graft Loss and Therapeutic Innovations
Camille Kotton, MD, FIDSA, FAST
Albert Einstein College of Medicine

CMV & AMR in Transplant: A Focus on Graft Loss and Therapeutic Innovations

Start

Activity Details

Free CME
0.75 AMA PRA Category 1 Credits
Released: August 30, 2018
Expires: August 29, 2019
45 minutes to complete

Provided by

Media

Internet

Target Audience

Healthcare providers who manage cytomegalovirus (CMV) infection and/or antibody-mediated rejection (AMR) in patients who undergo transplant.

Learning Objectives

  • Implement prophylactic and preventive anti-CMV therapy in at-risk transplant patients as recommended by the current evidence base
  • Promptly diagnose transplant patients with CMV infection and disease, using new and emerging assays and tools
  • Apply clinical trial data for new and emerging treatment options to manage transplant patients infected with CMV, including those with resistant or refractory disease
  • Select appropriate therapeutic agents using evidence-based protocols to prevent and treat AMR based on the pathophysiological underpinnings of the disease
  • Integrate an understanding of the contribution of human leukocyte antigen (HLA) antibodies and complement deposition in transplant glomerulopathy (TG) and graft loss into the management of AMR

Faculty

Camille Nelson Kotton, MD, FIDSA, FAST (Chair)
Clinical Director, Transplant and Immunocompromised Host Infectious Diseases
Infectious Diseases Division
Massachusetts General Hospital
Associate Professor
Harvard Medical School
Past Chair, Infectious Disease Community of Practice, American Society of Transplantation
Boston, Massachusetts (USA)


Deepali Kumar, MD, MSc, FRCP(C), FAST
Associate Professor of Medicine
Transplant Infectious Diseases & Multi Organ Transplant Program
University Health Network
Toronto, Ontario (Canada)


Alexandre Loupy, MD, PhD
Professor of Nephrology and Epidemiology
Department of Nephrology and Kidney Transplantation
Hôpital Necker / INSERM U970
Paris, France (Europe)


Disclosure of Conflicts of Interest

The “Conflict of Interest Disclosure Policy” of Albert Einstein College of Medicine requires that faculty participating in any CME activity disclose to the audience any relevant relationship(s) with a pharmaceutical, product, or device company. Any presenter, whose disclosed relationships prove to create a conflict of interest with regard to their contribution to the activity, will not be permitted to present.

Albert Einstein College of Medicine also requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. Albert Einstein College of Medicine, CCME staff, has no relevant conflicts of interest with commercial interests related directly or indirectly to this educational activity.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

  • Camille Nelson Kotton, MD, FIDSA, FAST, has affiliations with Chimerix, Merck, and Oxford Immunotec (Consulting Fees); Astellas, Merck, and Shire (AdjudicationCommittees).
  • Alexandre Loupy, MD, PhD, has no affiliations to disclose.
  • Deepali Kumar, MD, MSc, FRCP(C), FAST, has affiliations with Oxford Diagnostics and Qiagen (Consulting Fees); Oxford Diagnostics, Qiagen, and Roche (Contracted Research).

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

RMEI Medical Education, LLC

  • Sherri Kramer, MD, has no affiliations with commercial interests to disclose.
  • Sharon Powell has no affiliations with commercial interests to disclose.

The following Einstein peer reviewer reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

  • Amit Verma, MD, has no affiliations with commercial interests to disclose.

The following Einstein CME reviewer reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

  • Victor B. Hatcher, PhD, has no affiliations with commercial interests to disclose.

Albert Einstein College of Medicine, CCME staff, and RMEI Medical Education, LLC, have no relevant conflicts of interest with commercial interests related directly or indirectly to this educational activity.

Joint Accreditation Statement

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Albert Einstein College of Medicine and RMEI Medical Education, LLC. Albert Einstein College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

The Albert Einstein College of Medicine designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

How to Receive Credit

By reading the course content and successfully completing the post-test and evaluation, physicians, nurse practitioners, and PAs are entitled to receive up to 0.75 AMA PRA Category 1 Credit(s)™. A statement of credit will be available to print from your user history page. Users must:

  • Read the learning objectives and faculty disclosures.
  • Participate in the activity.
  • Complete the activity evaluation.

Physicians, nurse practitioners, and PAs who successfully complete the post-test and evaluation will receive CME credit. You must score 75% or higher on the post-test to receive credit for this activity. All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.

YOUR FEEDBACK IS IMPORTANT!

Complete the Evaluation form for this activity and be entered into a drawing for a $100* Amazon Gift card.
*The expense for this gift card is solely funded by RMEI Medical Education, LLC. No supporter funding was used for the expense of this gift card.

Rules and Regulations 
This sweepstakes is managed by RMEI Medical Education, LLC (RMEI), a full-service medical education company. The winner will be selected via automated random drawing on a monthly basis from among all eligible entries and notified through the contact information provided. In accordance with our privacy policy, we do not share your information with any third parties. By entering the sweepstakes, you grant RMEI permission to use your email address to reach you for notification and prize fulfillment. Only individuals who complete the evaluation forms and provide contact information will be eligible to win. Open to those who have a US postal address and who are 18 years or older. Only one prize per person and per household will be awarded. The prize will be a $100 Amazon gift card.

Statement of Commercial Support

This activity is supported by independent medical educational grants from Merck and Shire.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Hardware/Software Requirements

Pro-CME recommends using the latest versions of these supported browsers: Google Chrome, Microsoft Internet Explorer, Mozilla Firefox, Safari. Depending on your browser of choice, additional software, such as Adobe Reader® and Adobe® Flash® Player may be required.

Surgery Presentations

0.75 CME
Albert Einstein College of Medicine
CMV & AMR in Transplant: A Focus on Graft Loss and Therapeutic Innovations

CMV & AMR in Transplant: A Focus on Graft Loss and Therapeutic Innovations

Start

Activity Details

Free CME
0.75 AMA PRA Category 1 Credits
Released: August 30, 2018
Expires: August 29, 2019
45 minutes to complete

Provided by

Media

Internet

Target Audience

Healthcare providers who manage cytomegalovirus (CMV) infection and/or antibody-mediated rejection (AMR) in patients who undergo transplant.

Learning Objectives

  • Implement prophylactic and preventive anti-CMV therapy in at-risk transplant patients as recommended by the current evidence base
  • Promptly diagnose transplant patients with CMV infection and disease, using new and emerging assays and tools
  • Apply clinical trial data for new and emerging treatment options to manage transplant patients infected with CMV, including those with resistant or refractory disease
  • Select appropriate therapeutic agents using evidence-based protocols to prevent and treat AMR based on the pathophysiological underpinnings of the disease
  • Integrate an understanding of the contribution of human leukocyte antigen (HLA) antibodies and complement deposition in transplant glomerulopathy (TG) and graft loss into the management of AMR

Faculty

Camille Nelson Kotton, MD, FIDSA, FAST (Chair)
Clinical Director, Transplant and Immunocompromised Host Infectious Diseases
Infectious Diseases Division
Massachusetts General Hospital
Associate Professor
Harvard Medical School
Past Chair, Infectious Disease Community of Practice, American Society of Transplantation
Boston, Massachusetts (USA)


Deepali Kumar, MD, MSc, FRCP(C), FAST
Associate Professor of Medicine
Transplant Infectious Diseases & Multi Organ Transplant Program
University Health Network
Toronto, Ontario (Canada)


Alexandre Loupy, MD, PhD
Professor of Nephrology and Epidemiology
Department of Nephrology and Kidney Transplantation
Hôpital Necker / INSERM U970
Paris, France (Europe)


Disclosure of Conflicts of Interest

The “Conflict of Interest Disclosure Policy” of Albert Einstein College of Medicine requires that faculty participating in any CME activity disclose to the audience any relevant relationship(s) with a pharmaceutical, product, or device company. Any presenter, whose disclosed relationships prove to create a conflict of interest with regard to their contribution to the activity, will not be permitted to present.

Albert Einstein College of Medicine also requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. Albert Einstein College of Medicine, CCME staff, has no relevant conflicts of interest with commercial interests related directly or indirectly to this educational activity.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

  • Camille Nelson Kotton, MD, FIDSA, FAST, has affiliations with Chimerix, Merck, and Oxford Immunotec (Consulting Fees); Astellas, Merck, and Shire (AdjudicationCommittees).
  • Alexandre Loupy, MD, PhD, has no affiliations to disclose.
  • Deepali Kumar, MD, MSc, FRCP(C), FAST, has affiliations with Oxford Diagnostics and Qiagen (Consulting Fees); Oxford Diagnostics, Qiagen, and Roche (Contracted Research).

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

RMEI Medical Education, LLC

  • Sherri Kramer, MD, has no affiliations with commercial interests to disclose.
  • Sharon Powell has no affiliations with commercial interests to disclose.

The following Einstein peer reviewer reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

  • Amit Verma, MD, has no affiliations with commercial interests to disclose.

The following Einstein CME reviewer reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

  • Victor B. Hatcher, PhD, has no affiliations with commercial interests to disclose.

Albert Einstein College of Medicine, CCME staff, and RMEI Medical Education, LLC, have no relevant conflicts of interest with commercial interests related directly or indirectly to this educational activity.

Joint Accreditation Statement

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Albert Einstein College of Medicine and RMEI Medical Education, LLC. Albert Einstein College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

The Albert Einstein College of Medicine designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

How to Receive Credit

By reading the course content and successfully completing the post-test and evaluation, physicians, nurse practitioners, and PAs are entitled to receive up to 0.75 AMA PRA Category 1 Credit(s)™. A statement of credit will be available to print from your user history page. Users must:

  • Read the learning objectives and faculty disclosures.
  • Participate in the activity.
  • Complete the activity evaluation.

Physicians, nurse practitioners, and PAs who successfully complete the post-test and evaluation will receive CME credit. You must score 75% or higher on the post-test to receive credit for this activity. All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.

YOUR FEEDBACK IS IMPORTANT!

Complete the Evaluation form for this activity and be entered into a drawing for a $100* Amazon Gift card.
*The expense for this gift card is solely funded by RMEI Medical Education, LLC. No supporter funding was used for the expense of this gift card.

Rules and Regulations 
This sweepstakes is managed by RMEI Medical Education, LLC (RMEI), a full-service medical education company. The winner will be selected via automated random drawing on a monthly basis from among all eligible entries and notified through the contact information provided. In accordance with our privacy policy, we do not share your information with any third parties. By entering the sweepstakes, you grant RMEI permission to use your email address to reach you for notification and prize fulfillment. Only individuals who complete the evaluation forms and provide contact information will be eligible to win. Open to those who have a US postal address and who are 18 years or older. Only one prize per person and per household will be awarded. The prize will be a $100 Amazon gift card.

Statement of Commercial Support

This activity is supported by independent medical educational grants from Merck and Shire.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Hardware/Software Requirements

Pro-CME recommends using the latest versions of these supported browsers: Google Chrome, Microsoft Internet Explorer, Mozilla Firefox, Safari. Depending on your browser of choice, additional software, such as Adobe Reader® and Adobe® Flash® Player may be required.